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extra expenses of multiple seinings and sorting common to most polyculture situations. Any remaining trout not captured during the spring
harvest would not be totally wasted incatfish production ponds.
Rainbow trout can be successfully and economically reared during the winter season insouthern Arkansas. Profits of $44.00 per 0.9 m1cage
and $780.00 per hectare are obtainable. Producers should stock trout weighing at least 113 g to obtain marketable size fish inone growing season.
Smaller operations should sell their fish on local markets to both obtain higher prices and take advantage of the maximum length of the growing
season. Most trout growth is obtained during November and December and again near the latter part of the season during March and Aprilwhen
water temperatures range between 10-16° C.

Table 1. Net production, food conversion efficiency,

percent survival,and average weight gained for rainbow trout reared incages.
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Table 2. Net production, food conversion efficiency,

percent survival, and average weight gain for rainbow trout production in Arkansas ponds.
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Figure 1 Average weekly water temperature of a 1.6 ha pond at 0.5
meter depth insoutheast Arkansas during the winter of 1979-80.
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THE STATE OF CYTIDINE 3,5 CYCLIC MONOPHOSPHATE (CYCLIC CMP) RESEARCH
The status of cyclic CMP is unclear although the presence of cyclic CMP radioimmunoreactive material (CRIRM) has been demonstrated in
a variety of biological tissues and fluids. Furthermore, marked changes in cyclic CMP and CRIRM have occurred at certain times after partial
hepatectomy during liver regeneration. In addition, CRIRM is known to increase in cell free systems thought to synthesize the nucleotide from
triphosphate. Several cyclic CMP phosphodiesterases have been demonstrated. Argument about the occurrence of cyclic CMP has
withboth unlabeled authentic cyclic CMP and 'H-cyclic CMP on a number of TLC systems,
ibecause although CRIRM co-chromatographs
Mhas a different Rf from that of 3H-cyclic CMP or unlabeled cyclic CMP on Dowex-1 -formate anion exchange chromatography of acid
le extracts of biological tissue.
The discovery of cyclic AMP and the development of the second messenger concept constituted a revolution inbiological thinking (Sutherland, 1972). In contrast, after almost ten years ofresearch incyclic CMP,it remains uncertain that this nucleotide is a naturally occurring compound or that ithas any biological function at all.For example, in 1980 the onlypublications in this area were two abstracts on cyclic CMphospodiesterases (PDE) (Conrad and Bloch, 1980; Helfman et al., 1980), and another communication (Murphy and Stone, 1980) on apparent changes in
cyclic CMP concentration during liverregeneration. In1981, only two communications have appeared so far; (Wikberg and Wingren, 1981) one
on non-identity of CRIRM with authentic cyclic CMP and (Scavennec et al., 1981) the other on the occurrence of cyclic CMP in the urine of
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normal and leukemia patients. Thus, itis possible to review the salient points of the literature in this area ina very short paper and, in so doing,
explain the reasons for the difficulties.
Cyclic CMP was synthesized in 1961 by Smith et al., along with the cyclic analogs of the monophosphates of adenosine, guanosine and
uridine. When Steiner and his group (1972) developed radioimmunoassays for most of the cyclic nucleotides, cyclic CMP was omitted. 'The reason
was that cyclic CMP isinsoluble inpyridine, the solvent used in the succinylation reaction which attaches a succinyl moiety at the 2 position of
the ribose while succinic anhydride serves as the reagent. The succinyl moiety at position 2 serves several very important functions in the development and function of a radioimmunoassay: 1) Itserves as a point of attachment for a large protein molecule which makes the compound antigenic when injected, along withFruend's reagent, into the toe pads of rabbits; 2) It serves as a point of attachment for a methyl tyrosine moiety,
which, in turn, is iodinated with '"I.The succinylation withsuccinic anhydride,
surprisingly, could have been carried out in water. The reactions
'
are shown inFigure 1. The highlyradioactive '"Imethyl tyrosine ester of 2 succinyl cyclic CMP binds to the antibody in the assay and can be displaced by cyclic CMP either as known standards or cyclic CMP present in unknown samples. Figure 2 demonstrates a radioimmunoassay control
curve.
Figure 3 shows the cross reactivity of the antibody with other cyclic nucleotides, most of which, with the exception of cyclic AMP, present
no problems. Radioimmunoassays of this type were developed almost simultaneously during 1978-79 (Cailla et al., 1978; Murphy and Stone, 1979)
and again recently (Wikberg and Wingren, 1981). A commercial assay from Collaborative Research, Walthan, Massachusetts, is also available.
However, it should be emphasized that the founder of this area ofresearch is actually Alexander Bloch of the Roswell Park Memorial Institute, who, from1970 to the present, has accomplished the followingbasic research:
1) He has demonstrated that cyclic CMP is present inrelatively large amounts (nMoles) in mammalian liver, L1210 cells
and that itincreases inregenerating liver.Bloch characterized cyclic CMP in a number of ways: Rf values in eight different
thin layer chromatographic (TLC) solvent systems, electrophoretic mobilityin three different buffers, UVspectra, and mass
spectral analysis (Bloch, 1974a).
2) He has demonstrated that the addition of cyclic CMP to L1210 cells, which had previously been synchronized by cooling to 4° C, produced a burst of mitotic activity. He concluded that the cultures had been synchronized at the Gi phase since
the cells could not likelytraverse the cell cycle in 15-30 min. Thus, Bloch was the first to associate cyclic CMP withthe mitotic
phase. He also showed that the addition of cyclic CMP reversed the inhibition of growth produced by cyclic AMP in the L
1210 cultures (Bloch etal., 1974).
Bloch considered that, despite all these data, definitive proof of cyclic CMP as a normal physiological cellular component had to await the
demonstration of its enzymatic synthesis inthe cell from which it had been isolated. Bloch did not have a radioimmunoassay available but was
forced to rely on TLCwhich is less accurate quantitatively and much more time consuming. Cyclic CMP has also been found in surprisingly high
concentrations (0.05-2.0 nM) in bacterial culture media from Corynebacterium murisepticus or microbacterium species (Ishiyama, 1975). The
biosynthesis of a molecule by a cell in which it has been found is important in proving its status as a normal metabolite, because otherwise, one
might conclude that caffeine, nicotine or aspirin are normal human metabolites. These compounds can be isolated from many individuals, are
metabolized by the body and have many pharmacological effects which mighteasily be mistaken for physiological functions.
Anumber of different phosphodiesterases (PDE's) have been described for cyclic CMP. One, which has been purified by Conrad and Bloch
(1980), is of relatively high molecular weight and low K and is apparently specific for cyclic CMP only. Another PDE, which has been purified by
m
Helfman et al., (1980), hydrolizes both cyclic AMP and cyclic CMP at different sites and has a molecular weight of only 33,000. Interestingly
enough, the cyclic CMP PDE's are not inhibited by the methyl xanthines as are the PDE's of the purine cyclic nucleotides.
++ orFe ++ as cofactors at neutral pH, reported
Cech and Ignarro (1977 and 1978) using alpha"P labeled CTP as substrate with either Ma
the biosynthesis of cyclic CMP in both mouse and rat liver homogenates, both normal and regenerating, as well as in other rodent tissues. The
product was reported as having been characterized with alumina column chromatography, on Dowex-1-formate, PEI cellulose, and recrystallization to constant specific activity in two solvents. However, Krishna (1979) showed that the presumed "P cyclic CMP had a different Rf from the
'H cyclic CMP marking pool. We investigated a similar system and found a large number of radioimmunoreactive compounds among the products of the reaction. Thus, this area is in complete disarray at the present time. Recently Wikberg et al., (1981) has demonstrated the problem
quite clearly (Fig. 4 and 5).
Figure 4 shows work carried out by Wikberg, who has developed a radioimmunoassay quite similar to the others, but which uses 5H cyclic
CMP as the labelled compound to be displaced from the antibody rather than '"L methyl tyrosine derivatives used in the other systems. This

figure compares to different chromatographs carried out on identical 0.9 X 15 cm AGl-X-8-formate coumns eluted with 0.2 N formic acid. One
column, the solid line, was loaded with perchloric acid soluble fraction from 3-5 grams of rat liver, and an identically loaded column was further
charged with 10 pMoles of JH cyclic CMP. The solid line represents radioimmunoreactivity, and the dotted line, radioactivity. Itis evident that
these peaks do not coincide. Figure 5is similar, but the tandem column was loaded with 10 pMoles of unlabeled cyclic CMP. In this figure, the
dotted line represents radioimmunoreactivity on the tandem column.
The treatment of CRIRM withpronase, a proteolytic enzyme, increases the radioimmunoreactive cyclic CMP material by a factor of 4 but
does not change its Rf Itshould be evident that a radioimmunoassay which does not distinguish between the compound it was designed to quantitate and a different uncharacterized material is of doubtful value.
CRIRM has been noted by others but has been assumed to be a peptide which binds cyclic CMP and which competes with the antibody for
the nucleotide. On the other hand, the material may be a peptide which is an artifact of extraction with perchloric acid and which has a sequence
of amino acids identical to some portion of the carrier protein molecule, originally used to make the antibody. This is not likelysince a variety of
proteins have been used as carriers among the radioimmunoassays in use.
Figure 6 (Murphy and Stone, 1980) was produced by measuring the changes in cyclic CMP in regenerating liver after partial hepatectomyThe animals were accompanied by suitable control groups. The perchlorate soluble supernatants were chromatographed upon 3 X 1 cm Dowex1-formate columns with0.1 formic acid. The samples in the peak tubes were further characterized by TLC in which the CRIRMmaterial was cochromatographed with JH cyclic CMP and unlabeled cyclic CMP.
It would be most interesting to ascertain if radioimmunoassayable reactive material similar to that isolated in cyclic radioimmunoassay
would be found for cyclic AMP and cyclic GMP in Wikberg type systems. The close approximation of the Rf of Wikberg's CRIRM peak with
cyclic CMP itself is a technical problem which must be solved before this area can progress.
Itis the opinion of Bloch. and also of the present authors, that cyclic CMP is a rather common cyclic nucleotide, but it is usually bound to
some cellular constituents(s), and it may appear in free form for only relatively short periods during some physiological process in a
analogous to norepinephrine or acetycholine.
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Figure 2. Standard immunoassay curve for cyclic CMP

.

Figure 1

Structures of cyclic CMP derivatives

synthesized.

Figure 4. Chromatography of cold perchloric acid extracts of rat
liver on large with »H cyclic CMP marking pool added. AG 1-X8

columns.

¦>.

Chromatography of cold perchloric acid extracts from rat
th unlabelled cyclic CMP added to tandem column. (From
getal., 1981).

(From Wikberg et al., 1981).

Figure 6. Changes in the cyclic CMP of rat liver following 70%
hepatectomy. (From Murphy and Stone, 1980).
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ANOMALIES OF BOBCAT SKULLS (FELIS RUFUS) INARKANSAS
Examination of 275 bobcat skulls (Felis rufus) from Arkansas, preserved in the Collection of Recent Mammals, Arkansas State
Museum of Zoology (ASUMZ), revealed fiveanomalous forms whichranged from dental irregularity to supernumerary cranial bones.

University

Sutural anomalies were found inseveral skulls. The normal junction of the coronal (C) and sagittal (S) sutures isillustrated in Figure 1, #
6926. This bregmatic junction forms after fontanelle ossification of the frontal and parietal bones. In the fetal skull, cartilagenous "soft spots" or
fontanelles exist at the future junctional site, and if ossification among the bones is uneven, waved or otherwise malformed sutures may result.
Two of the more pronounced sutural anomalies found inArkansas bobcats are illustrated inFigure 1, #'s 7706 and 6765. Bregmatic bone formation can also cause abnormal junctions ifankylosis obliterates one or more sutures (Pratt, 1942; Manville, 1959). We did not attempt to distinguish
between anomalies caused by these factors.
Bregmatic bones (those formed at the anterior fontanelle) occur commonly inthe beaver (Castor) and porcupine (Erethizori) (Schultz, 1923)
and result from one or more ossification centers developing in the anterior fontanelle, thereby forming additional bones as the parietals and
frontals complete ossification around them. Occurrences of bregmatic bones in bobcats are discussed in the literature (Pratt, 1942; Manville,
1959; Mahan, 1980). Hall and Kelson (1959) (probably unknowingly) depicted a bregmatic bone in their illustration of a bobcat skull. Bregmatic
fontanelle bones were found in 41 of 275 (14.9%) Arkansas bobcat skulls examined, and varied in size, shape, and number. Representatives of
variations seen in Arkansas skulls are illustrated inFigure 2. The nature of these bones inArkansas bobcats is similar to reports from other areas:
14.7% inNebraska (Mahan, 1980); 16.8% in Oregon, 14.6% in Nevada, 15.5% nationally (as represented in the U.S. National Museum) (Manville, 1959). Manville also pointed out deviations from this apparent trend: 37.5% of 32 specimens from West Virginia, 44.0% of nine from Mississippi and 7.0% of 158 from Texas. Pratt (1942) found anomalous bones in 17.5% of his museum study material, and Progulske (1952) found 15
of 72 (20.8%) skulls from Virginiaand North Carolina to have anomalous bones. Usually, only a single extra bone occurs; however, inthe Arkansas material examined, one skull (Fig. 2, tt 7471) exhibited two additional bones (0.4% of sample). Similarly, Mahan (1980) found only one such
pair of bones (0.9%) in Nebraska and Pratt (1942) reported two (0.12% ofhis sample). Furthermore, Pratt reported only one incidence involving
three anomalous bones in a sample of 2154 skulls. ASUMZ 7734 (Fig. 2) illustrates an Arkansas specimen exhibiting this trinity of extra bones
(0.4% of sample), representing the second documented record. No correlation was found between sex or geographic location and presence of
anomalous bones in Arkansas bobcats.
Wormian bones are those which are sutural in origin, as contrasted with bregmatic bones which are fontanellic in origin. Itis sometimes
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